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Abstract
Objective: To (i) evaluate the extent to which Coca-Cola’s ‘Transparency Lists’ of
218 researchers that it funds are comprehensive; (ii) map all scientiﬁc research
acknowledging funding from Coca-Cola; (iii) identify those institutions, authors
and research topics funded by Coca-Cola; and (iv) use Coca-Cola’s disclosure to
gauge whether its funded researchers acknowledge the source of funding.
Design: Using Web of Science Core Collection database, we retrieved all studies
declaring receipt of direct funding from the Coca-Cola brand, published between
2008 and 2016. Using conservative eligibility criteria, we iteratively removed
studies and recreated Coca-Cola’s transparency lists using our data. We used
network analysis and structural topic modelling to assess the structure,
organization and thematic focus of Coca-Cola’s research enterprise, and string
matching to evaluate the completeness of Coca-Cola’s transparency lists.
Results: Three hundred and eighty-nine articles, published in 169 different
journals, and authored by 907 researchers, cite funding from The Coca-Cola
Company. Of these, Coca-Cola acknowledges funding forty-two authors (<5%).
We observed that the funded research focuses mostly on nutrition and emphasizes
the importance of physical activity and the concept of ‘energy balance’.
Conclusions: The Coca-Cola Company appears to have failed to declare a
comprehensive list of its research activities. Further, several funded authors appear
to have failed to declare receipt of funding. Most of Coca-Cola’s research support
is directed towards physical activity and disregards the role of diet in obesity.
Despite initiatives for greater transparency of research funding, the full scale of
Coca-Cola’s involvement is still not known.
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There is longstanding concern that multinational companies
manufacturing products harmful to health fund research
seeking to prevent public health policies designed to
counter the effects of their products. Thanks to the
disclosure of tobacco industry documents, much has been
learnt about how that particular industry conducted research
designed to create confusion and to reframe the agenda in
ways that advanced its interests(1–4). Recently attention has
turned to similar activities by the food industry. In early
2015, Coca-Cola attracted extensive criticism when it was
revealed that it had funded a ‘Global Energy Balance Net-
work’ (GEBN), led by John Peters and James Hill (University
of Colorado), Gregory Hand (West Virginia University) and
Steven Blair (University of South Carolina), whose main
message was that there was no compelling evidence of a
signiﬁcant link between sugar-sweetened beverages and
obesity(5). The funding agreement with the GEBN was not
visible for public scrutiny, as none of the parties involved had
disclosed it on their websites, and it was made available by
the recipient universities only in response to requests
under freedom of information laws. However, the scale and
inﬂuence of hidden research by the food and beverage
industry are unclear and, so far, there has been a dearth of
research on the role of vested interests such as Coca-Cola’s.
One methodological challenge is identifying those articles
funded by speciﬁc actors. Previously, search tools such as
Web of Science, PubMed or MEDLINE have not facilitated
this. However, in 2008 Thomson Reuters implemented
a large-scale indexation of the paratextual information on
funding acknowledgement statements and made them
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available for searching in one of its databases, the Web of
Science Core Collection. Building on this innovation, we
developed an algorithm in R programming language that
crawls the results of a Web of Science search on funding
statements and scrapes, parses and compiles the metadata
from the studies identiﬁed by the search, so making it pos-
sible to review systematically research funded by Coca-Cola.
Using this new dimension of bibliometric analysis and
the innovative tool we designed, we undertook a sys-
tematic review of the extent of involvement of Coca-Cola in
funding nutrition research. We further took advantage of a
unique opportunity to evaluate the extent to which Coca-
Cola is transparent and comprehensive in its disclosures.
In September 2015, Coca-Cola published a ‘Transpar-
ency List’ of 115 ‘Health Professionals and Scientiﬁc
Experts’ and forty-three ‘Research Projects’ that it spon-
sored in the USA(6,7). Following this disclosure, some of
Coca-Cola’s subsidiaries and bottlers published similar
transparency lists for health and wellness partnerships and
ﬁnancial support of scientiﬁc research in the UK(8),
France(9) and Germany(10), in December of 2015, and in
Australia(11), New Zealand(12) and Spain(13), in March of
2016 (see online supplementary material 1 for the full lists
of health professionals and scientiﬁc experts).
Here, using this new instrument, we investigate the
following questions:
1. Are Coca-Cola’s transparency lists complete?
2. How many studies and authors are funded by the
Coca-Cola brand?
3. Which research topics and interventions are supported
by Coca-Cola funding?
4. Are Coca-Cola funded researchers declaring their links
to the company in their publications?
Materials and methods
Data
Following PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) guidelines, we reviewed
research supported by Coca-Cola funding using the Web of
Science Core Collection database(14). Starting in 2008
Thomson Reuters added funding acknowledgement and
competing interest statements to all the bibliographic
records of the Science Citation Index Expanded. This
retrieves the funding/competing interest paratextual infor-
mation in the published version of an article as well as
distinguishing between a conﬂict of interest and a funding
statement, and identiﬁes the entities that are acknowledged
as providing funding for the article – saving the user from
having to read the statements and identify the funding
sources manually. These changes, in contrast to other
existing databases, now enable users to search the database
for text strings (e.g. names of corporations) in the funding
acknowledgement section, either as a funding agency or
simply as part of a declared conﬂict of interest.
To our knowledge, Web of Science is the only biblio-
graphic database to index this information on a large scale
(Scopus developed a similar algorithm, but with a con-
siderably lower coverage of publications and for a shorter
time period; and, more recently, PubMed started adding
this information to the metadata of the publication records
it indexes).
To retrieve metadata from the literature searched, we
developed a web scraping tool that crawls the URL
address of any search run in the Core Collection
database of Web of Science. Our algorithm, written for R
software, runs sequentially over each study page in the
search results, parses the HTML code and scrapes user-
deﬁned ﬁelds for each publication (e.g. title, abstract,
authors and afﬁliated institutions), including the funding/
competing interest statement and a table compiled by
Web of Science that lists all the entities that provided
funding for the article, as reported by the authors
(the R script for the algorithm is provided in online
supplementary material 2).
We searched for all studies that included the string ‘cola’
in the ‘funding text’ ﬁeld, which indexes the entire funding
acknowledgement section as reported in the published
manuscript (see Fig. 1 and Appendix 1 for search strategy).
This broad search strategy identiﬁed 779 articles, pub-
lished between 2008 and June 2016, and included articles
that acknowledged both direct funding and competing
interests involving The Coca-Cola Company and all its
subsidiaries. In addition, the broad search term ‘cola’ also
yielded studies funded by other companies, such as
‘Pepsi-Cola’.
The questions set out above make an implicit separation
between the research funding activities of The Coca-Cola
Company and those of the Coca-Cola brand, which
includes all subsidiaries and bottlers around the world.
With this distinction in mind, we constructed two analy-
tical samples.
The ﬁrst sample is less restrictive, composed of all
studies directly funded by any company or institute part
of the Coca-Cola brand that were retrieved from our
search. This sample is used to answer question 2
(‘How many studies and authors are funded by the
Coca-Cola brand?’).
The second sample is a sub-sample of the ﬁrst, focusing
on those studies funded by The Coca-Cola Company and
its philanthropic arms in North America, and by the sub-
sidiaries and bottlers that participated in the ‘Transparency
Initiative’. This sample is used to answer the remaining
questions (1, 3 and 4).
Below, we describe all steps in the selection of the
studies and in the creation of the two analytical samples.
Study selection
The 779 studies produced by our search were screened for
the inclusion of the string ‘Coca-Cola’ (or any possible
variant, including afﬁliates of the main company, such as
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the Beverage Institute of Health and Wellness(15); see
Appendix 1 for a list of all variants) as a funding agency.
The goal of the initial screening was to parse through the
search results and only keep studies that report direct
receipt of funding from The Coca-Cola Company or any
afﬁliates (see Fig. 1).
This criterion thus excluded 318 studies. These were
studies where: (i) the authors only declare a competing
interest due to previous relationships with The Coca-Cola
Company unrelated to research funding (e.g. speaking
engagements or consultancy work); (ii) Coca-Cola’s
involvement in the publication was indirect (e.g. via
student grants); (iii) the authors acknowledge funding
from another ‘cola’, such as ‘Pepsi-Cola’; and (iv) where
the algorithm used by Web of Science mistakenly included
Coca-Cola as a funding agency, when the funding
acknowledgement section did not indicate direct funding
by the company to that particular study (this was assessed
by manually inspecting all funding statements).
To be eligible for our ﬁrst sample, studies had to
acknowledge funding from The Coca-Cola Company or
any of its afﬁliates, including The Coca-Cola Foundation
(TCCF, the philanthropic arm of the company), Coca-Cola
North America, The Beverage Institute for Health and
Wellness (an organization set up by The Coca-Cola
Company to support nutrition research)(15) and Coca-
Cola bottlers or subsidiaries outside the USA. This criterion
comprises the totality of the Coca-Cola brand in our data
and did not lead to the removal of any further studies.
Sample 1 is therefore comprised of 461 studies.
In the second sample, we imposed stricter eligibility
criteria to isolate those studies funded by The Coca-Cola
Company and its afﬁliates in the USA, France, Germany,
Spain, New Zealand and Australia, the only countries to
release records of their research funding efforts in the form
of transparency lists of funded scientiﬁc experts, which
were released in late 2015 and early 2016 (see full lists in
online supplementary material 1).
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Fig. 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram for the present systematic
review. This PRISMA diagram describes the study selection steps and identifies at what stage we arrived at analytical Samples 1
and 2. Seven hundred and seventy-nine records (i.e. publications) were retrieved from a search on the ‘funding text’ field in Web of
Science for any mention of ‘Cola’. From these records, 318 were excluded for not meeting the screening criteria (i.e. the study
acknowledging direct receipt of funding from Coca-Cola). After exclusion, we arrive at Sample 1, which contains all studies funded
by the Coca-Cola brand. We subset from Sample 1 only those studies funded by The Coca-Cola Company, its affiliates in the USA
and those subsidiaries that published transparency lists; this leads to the exclusion of seventy-two studies for not meeting the
eligibility criteria, which gives us Sample 2
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This criterion excluded seventy-two studies that were
funded by subsidiaries or bottlers other than the ones
listed above. Sample 2 is thus comprised of 389 studies.
Analysis
To answer the ﬁrst question, concerning how compre-
hensive was Coca-Cola’s transparency initiative, following
the revelation of its ﬁnancial backing of the GEBN, we
recreated Coca-Cola’s lists of ‘scientiﬁc experts’ and
‘research partnerships’ by carefully following the para-
meters laid out in Coca-Cola’s transparency disclosure(6,7),
using our own data on funding statements retrieved
from Web of Science (Sample 1). We then matched
our recreated list to the original ones published on
Coca-Cola’s websites(6–13). This was designed to identify
any discrepancy that could, potentially, reﬂect selective
disclosure on the Company’s part.
Coca-Cola included in its ‘Research and Partnerships’
lists the names of academics it funded or collaborated with
according to the following criteria (these can be found on
the company’s websites)(6–13): (i) funding agreements
sourced exclusively from The Coca-Cola Company,
The Coca-Cola Foundation, Coca-Cola North America,
Coca-Cola South Paciﬁc, Coca-Cola Australia Foundation,
Coca-Cola Oceania, Coca-Cola Germany and Coca-Cola
Spain; and (ii) activities and studies conducted between
January 2010 and December 2015.
To match these criteria, we started with the 461 studies
in Sample 1 and excluded the following: (i) studies pub-
lished before 2010 and after December 2015; (ii) studies
funded by Coca-Cola subsidiaries and bottlers, with the
exception of those listed above; (iii) studies written as part
of research consortia that were themselves funded by The
Coca-Cola Company, since the funding link between the
company and the publication is indirect (see online
supplementary material 1, Supplemental Table 1 for a
complete listing of such consortia); and (iv) authors who
were not listed as principal or co-investigators on the
Coca-Cola grant in the original funding statement, where
this information was made available (unfortunately, most
funding statements did not identify the main investigator
on the grant). We opted for a conservative method of
removing studies to guarantee, to the highest degree
possible, an approximation to the way Coca-Cola
compiled its own lists of funded researchers.
One hundred and thirty-eight studies did not meet the
eligibility criteria and were removed from the matching
procedure.
It should be noted that although there is a gap between
the time funding is awarded and the publication date of a
study, which suggests that we should restrict our para-
meters to publications from 2012 onwards, it is not clear
from the information provided by Coca-Cola that authors
of research published in 2010 would not be included in its
transparency list. In fact, it is the case that some studies
yielding publications in 2010 were still ongoing in
subsequent years. Furthermore, a large proportion of
authors who published in 2010 also appeared in published
research later on, which suggests that projects funded by
Coca-Cola were likely to have yielded more than one
publication over time. Therefore, the method we designed
to match our data to Coca-Cola’s lists includes research
published from 2010 onwards.
Notwithstanding, to conﬁrm the validity of our method,
we used a sub-sample of studies published between 2012
and 2015 to compare with Coca-Cola’s transparency lists;
the results lend further support to our ﬁndings using
studies published from 2010 onwards (see ‘Limitations of
the study’ section below).
After exclusion of ineligible studies, the procedure
identiﬁed 907 authors, responsible for 331 studies that ﬁt
the criteria used by Coca-Cola to compile its lists of funded
research partnerships. The combined transparency lists
published by Coca-Cola in the USA, UK, Australia, France
and Germany (Spain and New Zealand did not contain
names of individual researchers) named 218 researchers.
We then proceeded with matching the names of the 907
authors we identiﬁed in our data to the 218 names of
researchers listed by Coca-Cola as recipients of its research
funding, using whole and approximate string matching
with manual veriﬁcation of the results.
Figure 2 summarizes this iterative method in a PRISMA-
type diagram.
The second question raised above seeks to reveal the
universe of scientiﬁc literature funded by Coca-Cola. For
this question, we focused on the Coca-Cola brand as a
whole, not making any distinction between the research
funding activities carried out by the main company in the
USA and those of its subsidiaries and bottlers around
the world.
To address this question, we employed network
analysis tools to visually portray the scope of Coca-Cola’s
involvement in funding scientiﬁc research, and at the same
time compare it with the company’s disclosure following
its transparency initiative. We built co-authorship
networks for all studies that were funded by the Coca-
Cola brand between 2008 and 2016. The diagrams show
nodes (authors) linked via edges, which represent the
co-authorship of a study. A similar approach has been
used in the literature combining a systematic review
with co-citation networks, instead of co-authorship
networks(16,17).
Network analysis was paired with text analysis to assess
the content of the scientiﬁc literature funded by Coca-Cola.
In addressing question 3, we shift our focus to the funding
endeavours of the Coca-Cola Company and those afﬁliates
that participated in the transparency initiative, and discuss
who and what ﬁelds of research they funded between 2008
and 2016. We added a new co-authorship network and ran
a community search algorithm(18) to uncover highly cohe-
sive subgroups that may indicate the presence of different
research hubs throughout the USA (and abroad).
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The algorithm calculates betweenness centrality scores for
each tie in the network, a metric that counts the number of
shortest paths between all pairs of nodes that pass through
each tie. In short, it counts how often a tie is used as a
‘bridge’ to connect, in the shortest way possible, any two
pair of nodes. It proceeds by removing the tie with the
highest score of betweenness, recalculating tie betweenness
centrality and iteratively removing ties with the highest
betweenness score until the network becomes disconnected
into several subgroups. Once it achieves an optimal number
of subgroups, the partitioning of the network is complete
and it assigns different colours to each subgroup.
This methodology offers valuable insights on the
structure and organization of Coca-Cola’s research enter-
prise, as it furthers our understanding of its centralization,
which actors are important and whether research themes
or institutions may play a role in its organization. Fur-
thermore, it puts Coca-Cola’s transparency initiative in
perspective, both in terms of scope (how complete is the
disclosure) and in terms of relevance (whether the authors
the company acknowledge as recipients of funding are
central or peripheral players in the network).
To better understand the research themes of Coca-
Cola’s funded research (the second part of question 3), we
examined the abstracts of all 389 articles that met the
screening and eligibility criteria that underpinned Sample
2. Using structural topic modelling(19), a variant of the
large toolbox of topic modelling estimation methods,
generally described as unsupervised machine learning
algorithms for probabilistic classiﬁcation of large text cor-
pora, we uncovered hidden semantic structures, or topics,
that give us an insight into the different streams of research
that Coca-Cola has funded since 2008.
In a nutshell, topic models estimate latent topics in a
bundle of text documents and simultaneously assign the
documents to the different topics, probabilistically. The
algorithm works on the assumption that a document is
composed of a different mixture of topics and estimates
the probability distribution of documents to topics; it does
this based on the semantic content of each document by
leveraging information on the word frequency within and
across documents. Thus, documents that share the same
semantic structure (i.e. similar distributions of word fre-
quencies) are likely to belong to the same topic.
In online supplementary material 3 we present in
greater detail the estimation methods and robustness tests
for the models presented here.
In the next section, the results are organized and dis-
cussed around each of the research questions set out above.
Results
Testing the completeness of Coca-Cola’s
transparency lists
Our search in Web of Science identiﬁed a total of 907
authors corresponding to 331 studies. These were the studies
that met the eligibility criteria required to match their authors
onto Coca-Cola’s transparency lists (for a full list of the stu-
dies included in Sample 1, Sample 2 and in the sample used
to match against Coca-Cola’s transparency lists, see online
supplementary material 1, Supplemental Table 2).
To evaluate the degree of transparency, ﬁrst we com-
pared the 907 names with the 218 researchers and scien-
tiﬁc experts named directly by the company and selected
subsidiaries as recipients of its own research funding.
Forty-two people appear in both sets (see Fig. 2). This
corresponds to 20% of the names on Coca-Cola’s trans-
parency lists and to 4% of the names listed in Web of
Science as authors of Coca-Cola funded publications.
Next we performed a series of robustness checks and
tests for alternative possibilities.
First, as only one researcher per publication could be
the direct recipient of a grant, we removed all publications
involving any of the forty-two authors whom we identiﬁed
successfully. There still remained 527 authors corre-
sponding to 152 published articles that acknowledge
Coca-Cola funding but were not named on Coca-Cola’s
transparency lists.
Second, we surveyed via email 131 (fewer than 152
because of overlap) corresponding authors requesting
whether they had received funding from Coca-Cola or not
during the period 2010 to 2015, using the corresponding
email address indicated in the manuscript. Each corre-
sponding author was emailed twice over the course of
20 d. It should be noted that the corresponding author is,
in many cases, a junior researcher on a publication, thus
unlikely to be the principal investigator on the grant.
Eleven per cent (fourteen authors) conﬁrmed Coca-Cola
funding, 22% (twenty-nine authors) denied it and 53%
(sixty-eight authors) did not reply. In cases where the
respondent denied funding, we asked who were the pri-
mary recipient(s) of the grant. The remaining 14% of email
addresses were no longer valid.
We altered our sample according to the results of the
survey in the following manner: (i) in the cases where the
respondent denied funding, we removed the respondent’s
name from the sample and, in the few cases where the
respondent provided the name of the primary recipient(s)
of the grant, we kept the latter’s name in the sample; and
(ii) in cases where the respondent conﬁrmed receipt of
funding, we removed the names of all co-authors on each
publication of the respondent in the sample.
After incorporating the results from the survey, our search
identiﬁed up to 471 authors corresponding to 128 articles
whose names do not appear on Coca-Cola’s lists, but whose
articles acknowledge funding from the company.
Mapping the universe of Coca-Cola’s research
funding: a network analysis
Next, we did a broad search for all published research
acknowledging ﬁnancial support from any member of
the Coca-Cola brand (including the main company,
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subsidiaries, bottlers and other afﬁliates), for the entire
period for which we have data, 2008 to 2016.
Figure 3 depicts a network of co-authorships, where
nodes represent authors and ties represent shared pub-
lications between them, for all publications that
acknowledge funding from the Coca-Cola brand. Thicker
lines denote a higher number of co-authored publications
between any two nodes. Nodes were sized by degree
centrality, a network measure that captures how central is
a node in the network by adding up the weights of its ties
(in this case, it will reﬂect the total number of co-authored
publications for each author).
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Full-text articles assessed for eligibility
in Sample 1
Articles published between
2010 and 2015
Funded by Coca-Cola &
subsidiaries in
‘transparency initiative’
(excludes subsidiaries
without transparency lists
and publications by Coca-
Cola funded research
consortia)
Only includes principal and
co-investigators on the grant
(when this information is
made available in the
funding statement)
Records excluded
(n 130)
Records screened that met eligibility
requirements and were used to
match its authors to Coca-
Cola’s transparency lists below:
Articles, n 331
Authors, n 907
Journals, n 157
List 1
‘Health Professionals
& Scientific Experts
in North America’
(n 115)
List 2
‘Research &
Partnerships in North
America’
(n 40)
List 3
‘Research &
Partnerships for UK,
Australia, Germany
and France’
(n 63)
Matched (n 42)
Authors of Coca-Cola funded
articles not listed in Coca-Cola’s
transparency lists:
Articles, n 152
Authors, n 527
Journals, n 107
Email survey sent to 131 lead
authors from the 152 journal articles
(less than 152 due to overlap)
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Fig. 2 Flow diagram of the process to match Web of Science data to Coca-Cola’s transparency lists. This flow-type diagram
describes: (i) the steps taken to recreate Coca-Cola’s transparency lists using our data; and (ii) the matching of our recreated list to
Coca-Cola’s combined transparency lists. We start with all studies in Sample 1 and begin evaluating them against the parameters
that governed Coca-Cola’s lists of scientific experts and researchers it funded, and excluding those that failed to meet the eligibility
criteria. In the matching stage, we combined the lists of researchers funded by Coca-Cola in North America, UK, Australia, Germany
and France and matched these names to those on the list we created using data from Web of Science. The corresponding author on
studies with all unmatched names were surveyed via email and asked about Coca-Cola funding
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The colour partitioning of the network allows us to
compare Coca-Cola’s disclosure with the known universe
of Coca-Cola funded research since 2008. Nodes marked
in red represent the forty-two authors whom we were able
to match to Coca-Cola’s transparency lists. Nodes in green
represent authors on studies (from Sample 2) that declared
funding from The Coca-Cola Company, Coca-Cola North
America, Beverage Institute for Health and Wellness and
The Coca-Cola Foundation, but who were not acknowl-
edged in the company’s transparency list. Finally, we
extend the network to the whole brand (Sample 1) by
colouring in purple nodes representing authors of studies
funded by Coca-Cola subsidiaries, bottlers or afﬁliate
companies that share the brand name around the world,
such as Coca-Cola Brasil and Coca-Cola Hellas, and
who were equally absent from those subsidiaries’ trans-
parency lists.
The network analysis reveals that the researchers
acknowledged by Coca-Cola, albeit occupying a central
position in the graph, represent only a small subset of the
universe of research reporting Coca-Cola funding, which
involves 1496 different researchers (we assume not all
grant recipients) and 12 412 co-authorship ties, corre-
sponding to 461 publications funded by the brand. The
network is sufﬁciently disconnected for us to ﬁnd several
self-contained cliques of researchers, detached from the
main component of the graph, and whose names did not
feature in any of Coca-Cola’s lists. In other words,
Coca-Cola’s transparency list appears to cover only
a small portion of research in which the company is
involved.
Additionally, the network structure shows several highly
dense and autonomous research groups, disconnected
from the main component of the network, and with no ties
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Fig. 3 Network of linkages between authors of publications acknowledging Coca-Cola related funding. This network graph shows
co-authored publications (ties) between authors (nodes), for publications that acknowledge funding from The Coca-Cola Company,
The Coca-Cola Foundation, the Beverage Institute for Health and Wellness and any subsidiary or bottler company (e.g. Coca-Cola
Brasil). Nodes in red identify authors who appear on Coca-Cola’s transparency lists. Nodes in green identify authors on Coca-Cola
funded publications whose names do not appear in Coca-Cola transparency lists. Nodes in purple identify authors on publications
funded by Coca-Cola subsidiaries, also not on Coca-Cola’s lists. Nodes are sized by degree centrality (total number of co-authors
times the number of shared publications they have)
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to the researchers acknowledged by the company. In
addition, there are other equally central nodes in the
network that were not acknowledged by Coca-Cola. This
suggests the company is funding several research groups
but has acknowledged only a subset.
However, a caveat to this visual assessment of the
completeness of Coca-Cola’s lists is that it includes a small
portion of publications that precede the start date of these
lists (2010) and publications funded by subsidiaries that
did not participate in the transparency initiative of the
main company.
Who and what is The Coca-Cola Company funding?
A topical analysis of abstracts
Now we turn to mapping who and what Coca-Cola is
funding, seeking to understand what areas of research and
who are the academics getting its ﬁnancial support.
Table 1 reports the most proliﬁc Coca-Cola funded
authors (see online supplementary material 1, Supple-
mental Table 3 for the top ﬁfteen institutional afﬁliations;
the metadata for the studies included in these two tables
are available upon request). As shown in Table 1,
the researcher who has published the most articles with
Coca-Cola funding is a former president of the American
College of Sports Medicine (S.B.). He has received around
$US 5·4 million of research funding to study the role of
energy balance at high levels of energy intake(7), and he also
played a pivotal role in the creation of the GEBN(5) (see
online supplementary material 1, Supplemental Table 4).
Other leading Coca-Cola researchers are: a former Dean
of the School of Public Health of West Virginia University
(G.H.), who was the Principal Investigator on ‘Energy
Flux – are we healthier when energy balance is achieved’
(funded with $US 851 000 by Coca-Cola), which resulted in
the Energy Balance Study(20), designed to evaluate the
impact of energy intake and expenditure on changes in
weight; and a member of the American Society for Nutrition
and the Canadian Diabetes* who received two unrestricted
grants ($US 192 000) in 2014 from Coca-Cola and has
argued that there is no convincing evidence that added
sugars in the diet have a unique impact on the development
of obesity or diabetes(21) (J.S.). His research showing there
is no association between total sugars intake and risk
of diabetes(22,23) has informed the Canadian Diabetes
Association’s position statements on sugars(24).
The large number of Coca-Cola funded studies
co-authored by the small group of academics in Table 1
suggests they ought to be central nodes in the network of
Coca-Cola funded research. To visualize their centrality,
we plotted a network of co-authorships using data from
Sample 2, restricted to research directly funded by The
Coca-Cola Company, The Coca-Cola Foundation, Coca-
Cola North America and the Beverage Institute for Health
and Wellness, thus excluding any subsidiaries or bottlers
outside the USA (see Fig. 4).
In addition to the community search algorithm we ran in
this network, as explained in the ‘Analysis’ section, we also
applied labels to researchers who were part of a closely
afﬁliated group of academics (with strong ties to
Coca-Cola) that was identiﬁed in email communications
with Coca-Cola ofﬁcials obtained via requests under
states’ open records laws (P Matos Serodio, G Ruskin, M
McKee et al., unpublished results). This offers an exogen-
ous benchmark to evaluate the performance of the network
community structure algorithm and to establish the validity
of using co-authorship data on Coca-Cola funded publica-
tions to shed light on the company’s involvement in funding
scientiﬁc research. The size of the labels varies with a
measure of node betweenness centrality, which shows the
number of times a researcher serves as a bridge between
any other two researchers in the network – this gives us an
idea of how important they are in controlling the ﬂow of
information in the network.
The coloured factions portray different research groups
funded by Coca-Cola. Their location in the graph may be
driven by geographical factors (such as university afﬁliation)
and by area of research – some authors may focus on
physical activity while others work on consumption of non-
nutritive sweeteners. Examples of such researchers include
Joanne Slavin and John Sievenpiper who focus their
research on sweeteners; this moves them close together, but
far from the core of the network, which is more attentive to
topics of physical activity. At the same time, Sievenpiper’s
afﬁliation to the University of Toronto pushes him away
from the core of the network, mostly based in the USA.
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Table 1 Top fifteen most frequent authors in Sample 2
Rank Researcher’s name
No. of
articles
On Coca-Cola’s
transparency list?
1 Steven Blair 89 Yes
2 Xuemei Sui 54 No
3 Timothy Church 51 Yes
4 Duck-Chul Lee 39 No
5 Peter Katzmarzyk 27 Yes
6 Carl Lavie 24 Yes
7 Gregory Hand 22 Yes
8 James Hébert 17 No
9 Mark Tremblay 17 Yes
10 Conrad Earnest 16 No
11 Steven P Hooker 15 No
12 William Koros 15 No
13 Olga Sarmiento 15 Yes
14 Robin Shook 15 No
15 Jean-Philippe Chaput 14 Yes
Sample 2 includes only those studies funded by The Coca-Cola
Company and its affiliates in the USA, France, Germany, Spain,
New Zealand and Australia, the only countries to release records of
their research funding efforts in the form of ‘Transparency Lists’ of
funded scientific experts, which were released in late 2015 and early 2016
(see full lists in online supplementary material 1). Sample 2 was compiled
by the authors using data retrieved from the Web of Science Core
Collection. The metadata for the studies included in this table are available
upon request.
* Note that the Canadian Diabetes Association became Diabetes Canada
on 13 February 2017(25).
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The match between coloured subgroups in the core of the
network and the location of researchers in close contact with
Coca-Cola suggests this group of academics was at the heart
of the company’s involvement in funding research, and in a
position to participate and coordinate studies between dif-
ferent research groups across ﬁelds and across borders,
connecting otherwise disconnected groups in the graph.
Turning to the themes of the research, we used structural
topic modelling. Figure 5 shows the distribution of topics
over documents and the seven most probable words for each
topic. As shown, topics converge on physical activity, energy
intake, weight, diabetes, exercise and obesity, which are
central themes in Coca-Cola’s effort to advance a research
agenda able to counteract the link between sugar con-
sumption and obesity by providing a secondary mechanism:
the lack of physical activity leading to energy imbalance.
Energy balance, physical activity, diabetes and obesity topics
account for over 50% of the studies we analysed (for an
interactive visualization of the twenty topics estimated see
online supplementary material 3, Supplemental Fig. 5).
Finally, we evaluate the inﬂuence of the Coca-Cola
funded publications based on journal impact factors.
Table 2 shows the top ﬁfteen journals publishing the
greatest numbers of Coca-Cola funded studies. This
included Medicine and Science in Sports & Exercise
(twenty-one articles) and other high-ranked journals such
as the American Journal of Clinical Nutrition, British
Journal of Sports Medicine and Journal of the American
Medical Association. The ﬁrst of these is published by the
American College of Sports Medicine, a recipient of sub-
stantial funding from Coca-Cola(26). These respected
journals lend these studies both credibility and visibility
within the academic community.
Testing whether Coca-Cola funded researchers
declare conﬂicts of interest
Next we ask whether the academics and scientiﬁc experts
who are acknowledged by the company as recipients of
research funds declare their ties to the company in
research publications.
When matching the names of researchers and
scientiﬁc experts on Coca-Cola’s list to our sample from
Web of Science, we failed to account for 176 scientiﬁc
experts (this includes people who were funded but may
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Fig. 4 Network of shared Coca-Cola funded publications. Nodes are authors, edges represent co-authored publications and are
sized by the number of co-authored publications between two nodes. Nodes are coloured by the edge-betweenness community
structure algorithm (explained in text); labels represent a network clique of Coca-Cola funded researchers, identified in personal
correspondence between academics and Coca-Cola officials obtained through freedom of information requests
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not necessarily be academics). These were persons whom
Coca-Cola declared as recipients of funding but did not
appear in our sample (note we were able to match
forty-two names). Possible explanations for this anomaly
are that the funded researchers did not disclose their
funding sources (whether intentionally or not), disclosed
them but the journal did not publish them, did not publish
in indexed journals, or were not active academic
researchers. To address the last possibility, we then
restricted the search further to only those listed on Coca-
Cola’s list whom we also were able to conﬁrm were aca-
demic researchers (afﬁliated with an academic institution
or actively involved in peer-reviewed research). This
yielded thirty-eight conﬁrmed academics. Searching
through each of their entire publications’ entries in Web of
Science, we were still unable to ﬁnd any declared conﬂicts
of interest.
Discussion
Our analysis employed a novel instrument to map the
scale, type and persons involved in Coca-Cola’s research
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activ, time, physic, day, mvpa, children, sedentari I Ratio = 5.7
pet, use, poli, phenol, active, yield, diffus l Ratio = 2.8
food, approach, develop, articl, use, research, method I Ratio = 2.8
fit, crf, men, associ, women, level, high I Ratio = 0.9
energi, beverag, intake, weight, consumpt, kcal, diet I Ratio = 3.8
cvd, men, associ, incid, diabet, strength, met I Ratio = 5.9
obes, bodi, bmi, group, intervent, school, measur I Ratio = 1.2
juic, fructos, effect, vitamin, trial, acid, differ I Ratio = 6.7
risk, mortal, year, age, diseas, cardiovascular, factor I Ratio = 3.1
exercis, effect, min, group, respons, concentr, train I Ratio = 1.7
activ, physic, transport, health, commut, citi , walk I Ratio = 1.5
countri, adolesc, implement, region, communiti, opportun, provid I Ratio = 3.1
symptom, support, use, perceiv, relationship, depress, assess I Ratio = 2.1
increas, function, muscl, perform, metabol, rate, chronic I Ratio = 4.6
data, review, valu, method, standard, health, use I Ratio = 1.1
predict, chang, show, mobil, term, human, time I Ratio = 5.9
water, non, model, effect, school, base, fiber I Ratio = 3.7
knee, cartilag, subject, mri, lesion, detect, assess I Ratio = 3.2
studi, data, differ, estim, result, within, provid I Ratio = 3.2
particip, associ, adult, variabl, model, popul, educ I Ratio = 1.1
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Fig. 5 Distribution of topics in the included literature. Based on an analysis of 389 documents from the structural topic model, this
graph shows the percentage of documents assigned to each topic. In a way, it measures the topic’s popularity within the corpus of
abstracts we retrieved from Web of Science. It is important to note that, although each abstract was assigned to a single topic in this
graph (the most probable topic), they are considered a mixture of topics; however, they often devote more words to a particular topic
and the algorithm used that information to assign the text to a single topic. The ratio value denotes, for each abstract, how dominant
was the most probable topic v. the second most probable topic; we averaged these out over all abstracts assigned to each topic in
the figure. For example, a ratio of 5·7 for topic 16 means that, on average, the weight of topic 16 in those abstracts assigned to it was
5·7 times larger than the second most probable topic in these abstracts. The twenty word stems with highest probability per topic are
listed in Supplemental Table 10 in online supplementary material 3. An interactive visualization of the twenty estimated topics is
available in Supplemental Fig. 5 in online supplementary material 3
Table 2 Selected journals of publication of the 389 Coca-Cola
funded articles in Sample 2
Journal
No. of
articles
Impact
factor
Medicine and Science in Sports and Exercise 21 4·141
American Journal of Clinical Nutrition 12 6·926
International Journal of Behavioural Nutrition
and Physical Activity
12 4·396
PLoS One 12 2·806
BMC Public Health 11 2·265
Polymer 11 3·364
American Journal of Preventive Medicine 9 4·020
Mayo Clinic Proceedings 9 6·686
Nutrients 8 3·550
British Journal of Sports Medicine 7 6·724
Obesity (Silver Spring) 7 3·873
British Journal of Nutrition 6 3·706
Journal of the American College of
Cardiology
6 19·896
Lancet 2 44·002
Journal of the American Medical Association
(JAMA)
1 44·405
Sample 2 includes only those studies funded by The Coca-Cola Company
and its affiliates in the USA, France, Germany, Spain, New Zealand and
Australia, the only countries to release records of their research funding
efforts in the form of ‘Transparency Lists’ of funded scientific experts, which
were released in late 2015 and early 2016 (see full lists in online supple-
mentary material 1). Sample 2 was compiled by the authors using data
retrieved from the Web of Science Core Collection.
10 PM Serôdio et al.
networks. It makes a series of important observations. First,
it revealed that Coca-Cola’s transparency lists released in
the USA(6,7), the UK(8), Australia(11), New Zealand(12),
France(9), Germany(10) and Spain(13) (see online supple-
mentary material 1, Supplemental Tables 5 to 9) are far
from complete. There were 471 authors in 128 studies
declaring Coca-Cola funding whose names did not appear
in any of the transparency lists. A further thirty-eight
researchers were on Coca-Cola’s lists, but their publications
indexed in Web of Science failed to declare Coca-Cola
funding or any conﬂict of interest. Second, the topical
modelling reveals a pattern of consistent themes across the
research publications funded by Coca-Cola, emphasizing
physical activity over sugar or energy intake in relation to
weight gain, diabetes and obesity.
Limitations of the study
Before interpreting the ﬁndings further, we must note
several limitations arising from the nature of the data used.
First, funding statements rarely identify the principal
investigator (or co-investigator) on a grant, which in this
case could overestimate the number of authors who
appear to have a direct tie to the company. To address this
issue, we surveyed the lead authors in each study that
acknowledged funding from Coca-Cola and, in the cases
where the lead author denied being involved on a
Coca-Cola grant, we inquired who were the principal and
co-investigators on the grant.
Second, funding statements rarely report the year in
which the grant was awarded. It is possible that some
studies were awarded grants by the company prior to 2010
but were published only post 2010, which may explain
why the author(s) did not appear on Coca-Cola’s trans-
parency lists. However, looking at a subset of articles
published in the period 2012–2015, we still found over 400
authors declaring funding from Coca-Cola who were not
acknowledged by the company. Furthermore, fourteen
authors, involved in twenty studies, conﬁrmed receiving
Coca-Cola funding directly to us in the period 2010 to 2015
but were not on Coca-Cola’s lists.
Third, Web of Science only started indexing funding
statements for articles published in 2008, which makes this
review a small subset of the overall population of
Coca-Cola funded studies. However, this asymmetry of
information may lead only to an underestimation of the
number of researchers funded by Coca-Cola. In addition,
our approach is also limited by the fact that Web of
Science is currently the only database indexing funding
statements in a systematic way, which restricts the
literature available for searching (see Appendix 2 for
more details).
Fourth, Coca-Cola has amended its transparency lists
multiple times. Using website crawling services that store
digital archives of the web, we have found that Coca-Cola
changed its list of ‘Research and Partnerships’ in the
USA at least four times between October 2015 and March
2016. The last change was ofﬁcially acknowledged by the
company as the ‘ﬁrst update’ to its public disclosure of
ﬁnancial support of scientiﬁc research. The update
deleted ﬁve and added eleven new names to the lists of
‘Health Professionals and Scientiﬁc Experts’ and ‘Research
and Partnerships’. The results reported above were
updated to include the most recent version of all lists
published online.
Fifth, authors may incorrectly report funding from The
Coca-Cola Company, when it fact it was awarded by a
subsidiary or bottler, or indeed awarded by Coca-Cola but
to their afﬁliated institution, not directly funding their
publication. Additionally, some researchers may
have refused to list their names on Coca-Cola’s website –
and although Coca-Cola acknowledges this issue on its
website, it also reveals the total amount of funding that
was allocated to said researchers was, on aggregate,
relatively small: ‘Several individuals with whom we
worked in the past have declined to have their names
listed. The aggregate amount of funding provided to
these individuals over the past ﬁve years is approximately
$38,000’(6).
Finally, it is possible that there are authors we have
missed who were not on Coca-Cola’s list and did not
disclose funding in their publications; omission of funding
source is, unfortunately, difﬁcult to observe and quantify,
making our results likely to be conservative estimates of
Coca-Cola’s apparent lack of transparency.
Conclusions
These observations have important implications for
managing potential conﬂicts of interest in research fund-
ing. We have learnt from past research that grants from
corporations in the tobacco, alcohol, pharmaceutical and
gambling industries can have signiﬁcant effects on the
results of published scientiﬁc research, although this
inﬂuence is often denied by those recipients of the
industry ﬁnancial support(27). A recent systematic review
of systematic reviews on the relationship between sugar-
sweetened beverages and weight gain found that industry-
sponsored studies were ﬁve times more likely to produce
results favourable to the companies(28). Even in cases
where the authors have complete independence to design,
implement and analyse the results of a study, the conﬂict
of interests created by industry funding may be enough to
compromise the integrity of the conclusions (a recent
Cochrane review concluded that standard ‘risk of bias’
assessments could not explain the bias found in pharma-
ceutical industry-sponsored studies, which suggests a
‘funding bias’ may be a better predictor)(29). In the worst-
case scenario, bias is introduced to the study design and
selection of hypotheses(30,31).
For policy, our results suggest a general lack of trans-
parency both among funders and researchers. Among
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industry, despite ostensible efforts of transparency, there
remains a signiﬁcant portion of Coca-Cola funded research
that appears to be in the dark. Prior to September 2015,
when Coca-Cola published its ﬁrst transparency list of
funded research and partnerships, it is hard to imagine that
the public health community and the public at large were
fully informed on the extent of Coca-Cola’s involvement in
funding research. In this paper, we have demonstrated
that even after an important step towards transparency
taken by the company, we still know very little about the
full scale of Coca-Cola’s funding efforts, let alone of the
entire soft drinks industry.
Turning to researchers, our results are consistent with
two publicised cases of researchers apparently failing to
declare conﬂicts. One such case involved Jeff Coombes, a
professor at the Centre for Research in Exercise, Physical
Activity and Health, from the University of Queensland,
whose research focuses on using exercise to treat meta-
bolic syndrome. In February of 2016, the Coca-Cola
Company reported that he received an ‘unrestricted gift’
of $US 100 000 from the company in 2014 to ‘support
ongoing research investigating the effect of exercise
intensity on Metabolic Syndrome’(32). However, out of
sixty-one publications of Professor Coombes between
2014 and 2016 that are indexed in Web of Science,* the
Coca-Cola Company is acknowledged as a funding source
on only four occasions, the ﬁrst in May 2016 (article
accepted in April 2016)(33), three months after Coca-Cola
publicly disclosed the details of Coombes’ grant and the
press coverage it generated(32). In fact, the funding
statement in the article provides a link to the webpage of
Coca-Cola Australia’s transparency list.
Another involved Fabrice Bonnet, a diabetes researcher
at the Institute for European Expertise in Physiology
(IEEP), who led a study between 2012 and 2014 to
determine whether daily consumption of sweeteners
included in carbonated soft drinks affected insulin sensi-
tivity. Bonnet reported funding from the IEEP when
registering a clinical trial on 8 January 2014 entitled
‘Comparison of the Effects of a 12-Week Consumption of
Two Carbonated Beverages on Insulin Sensitivity’(34).
However, The Coca-Cola Company acknowledged in
December 2016, on its French transparency disclosure(9),
having granted €719 000 to the IEEP for a ‘research project
on intense sweeteners’, for the period 2010 to 2014, which
comprises the entire length of Bonnet’s study, according to
the registered clinical trial(34). Bonnet’s clinical trial did not
acknowledge the ﬁnancial support to the IEEP provided
by Coca-Cola.
Such a lack of openness calls for reform and con-
sideration of alternative approaches for managing poten-
tial conﬂicts. Currently debates are being held about the
involvement of tobacco industries in e-cigarette
research(35) and some academic journals have taken the
strong measure of banning tobacco industry-funded stu-
dies altogether, arguing that they should be viewed as
‘marketing’ for the industry(36). Our ﬁndings suggesting a
lack of transparency in an industry that has claimed to be
fully open, contribute to a climate of distrust. This may
warrant the beginnings of a conversation about similar
restrictions on research funded by the sugar and related
industries.
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Box Research highlights
• There is concern in public health that The Coca-Cola
Company may fund research that beneﬁts its
corporate interests and diverts attention from the
role of sugar-sweetened beverages in the obesity
epidemic.
• In 2015, The Coca-Cola Company published several
lists of health professionals, scientiﬁc experts and
academic researchers with whom it collaborated
and whose research it funded between 2010 and
2015. It is not clear whether these lists are
comprehensive.
• The Coca-Cola Company, in conjunction with The
Coca-Cola Foundation and the Beverage Institute for
Health and Wellness, has funded 389 studies
between 2008 and 2016, published in 169 journals,
involving more than 1000 authors.
• Although Coca-Cola took a step towards
transparency, our data have shown major gaps and
errors in its disclosures of research funding: Coca-
Cola has acknowledged only forty-two out of 513
potential investigators on grants awarded by the
company.
• Coca-Cola predominantly funds research on
nutrition, with a focus on physical activity, the
concept of ‘energy balance’ and how these two
factors relate to obesity and diabetes.
* Here we focus on publications indexed by Web of Science. It is possible
that publications by Professor Coombes that were not indexed by Web of
Science may acknowledge funding from The Coca-Cola Company.
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Appendix 1
Literature searches
1. Web of Science search for systematic review using
Core Collection database: ft= “cola”
2. Web of Science search for variants of ‘Coca-Cola’:
fo= “coca-cola” OR fo= “coca cola” OR fo= “coco-cola”
OR fo= “cocacola” OR fo= “beverage health & wellness
institute” OR fo= “beverage institute for health & well-
ness” OR fo= “beverage institute for health wellness” OR
fo= “beverage institute for health and wellness”
Appendix 2
Limitations of Web of Science funding acknowl-
edgement data
The use of Thomson Reuters’ Web of Science Core Col-
lection to study funding sources in academic research is
not new(37,38). However, important limitations have been
raised in recent work(39,40).
Thomson Reuters began to index information contained
in the funding acknowledgement section of articles in 2008.
This means that the ﬁrst year with substantial coverage of
funding information in published research is 2009. The
database also presents other smaller caveats: (i) funding
acknowledgement data are covered mainly for the Science
Citation Index Expanded database, and not for Social Sci-
ence Citation Index or Arts and Humanities Citation Index
databases; (ii) information is indexed only for publications
where the funding text is in English; and (iii) it only indexes
information where the paratext includes mentions of
‘funding’ (other kinds of support are ignored).
For our purposes, these are minor caveats, except for
the fact that the sample is truncated, since we can look at
only a small window of Coca-Cola funding activities
because data before 2008 are missing.
However, other concerns have also been raised about
the way in which the algorithm determines whether the
company listed in the funding text is indeed a funding
agency for that study. Lewison and Sullivan(40) ﬁnd that
the algorithm over-classiﬁes companies as the funding
agencies in situations where they are simply included for
other monetary arrangements with an author which would
usually fall under a conﬂict of interest, and not a funding
contract for that particular study.
We worked around this by reading the funding paratext
for each publication and excluding those articles where
Coca-Cola is (mistakenly) listed as a funding agency
because there is simply a conﬂict of interest reported in
the funding acknowledgement.
Furthermore, another caveat we should note is the incon-
sistency of use of the author strings across publications. The
use of middle names, or ﬁrst name initials, changes frequently
across publications. To illustrate, S. Blair, Steven Blair, S N
Blair, Steven N Blair are variants of the same author’s name
used across publications. We standardize the author name
strings for all documents to avoid duplicates in our analysis.
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